These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15285981)

  • 1. Awareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial.
    Bourgeois M; Swendsen J; Young F; Amador X; Pini S; Cassano GB; Lindenmayer JP; Hsu C; Alphs L; Meltzer HY;
    Am J Psychiatry; 2004 Aug; 161(8):1494-6. PubMed ID: 15285981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
    Meltzer HY; Alphs L; Green AI; Altamura AC; Anand R; Bertoldi A; Bourgeois M; Chouinard G; Islam MZ; Kane J; Krishnan R; Lindenmayer JP; Potkin S;
    Arch Gen Psychiatry; 2003 Jan; 60(1):82-91. PubMed ID: 12511175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():41-5. PubMed ID: 9766619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients.
    Alphs L; Anand R; Islam MZ; Meltzer HY; Kane JM; Krishnan R; Green AI; Potkin S; Chouinard G; Lindenmayer JP; Kerwin R
    Schizophr Bull; 2004; 30(3):577-86. PubMed ID: 15631247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of concomitant psychotropic medication use during a 2-year study comparing clozapine and olanzapine for the prevention of suicidal behavior.
    Glick ID; Zaninelli R; Hsu C; Young FK; Weiss L; Gunay I; Kumar V
    J Clin Psychiatry; 2004 May; 65(5):679-85. PubMed ID: 15163255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comment on: "Lack of insight in schizophrenia: a review. Part I: theoretical concept, clinical aspects and Amador's model" of S. Raffard, S. Bayard, D., Capdevielle, F. Garcia, J.-P. Boulenger et M.-C. Gely-Nargeot].
    Caillard V
    Encephale; 2009 Sep; 35(4):400-1. PubMed ID: 19748378
    [No Abstract]   [Full Text] [Related]  

  • 7. What is specific to suicide in schizophrenia disorder? Demographic, clinical and behavioural dimensions.
    McGirr A; Turecki G
    Schizophr Res; 2008 Jan; 98(1-3):217-24. PubMed ID: 17942279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial.
    Potkin SG; Alphs L; Hsu C; Krishnan KR; Anand R; Young FK; Meltzer H; Green A;
    Biol Psychiatry; 2003 Aug; 54(4):444-52. PubMed ID: 12915289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The InterSePT suicide scale for prediction of imminent suicidal behaviors.
    Ayer DW; Jayathilake K; Meltzer HY
    Psychiatry Res; 2008 Oct; 161(1):87-96. PubMed ID: 18786729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the risk for suicide in schizophrenia and affective disorders.
    Meltzer HY; Baldessarini RJ
    J Clin Psychiatry; 2003 Sep; 64(9):1122-9. PubMed ID: 14628990
    [No Abstract]   [Full Text] [Related]  

  • 11. [Psychoses, mood, suicidal tendencies and clozapine].
    Llorca PM; Lançon C; Reine G
    Encephale; 1997; 23(6):431-6. PubMed ID: 9488925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current stakes in managing patients with schizophrenia].
    Kahn JP
    Encephale; 2006 Jan; 32 Pt 2():S14-5. PubMed ID: 16800081
    [No Abstract]   [Full Text] [Related]  

  • 13. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol.
    Tollefson GD; Sanger TM; Lu Y; Thieme ME
    Arch Gen Psychiatry; 1998 Mar; 55(3):250-8. PubMed ID: 9510219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options.
    Meltzer HY
    Curr Psychiatry Rep; 2002 Aug; 4(4):279-83. PubMed ID: 12126596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.
    Keck PE; Strakowski SM; McElroy SL
    J Clin Psychiatry; 2000; 61 Suppl 3():4-9. PubMed ID: 10724127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating suicidality as an outcome measure in clinical trials of suicide in schizophrenia.
    Sakinofsky I; Heila H; Krishnan R
    Schizophr Bull; 2004; 30(3):587-98. PubMed ID: 15631248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment.
    Meltzer HY; Okayli G
    Am J Psychiatry; 1995 Feb; 152(2):183-90. PubMed ID: 7840350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors related to suicide attempts in a Tunisian sample of patients with schizophrenia].
    Bouhlel S; M'solly M; Benhawala S; Jones Y; El-Hechmi Z
    Encephale; 2013 Feb; 39(1):6-12. PubMed ID: 23095582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine.
    Meltzer HY
    J Clin Psychiatry; 2005 Apr; 66(4):530-3. PubMed ID: 15816797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.